Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P100018/S053

Pipeline Flex Embolization Device (Pipeline Flex); Pipeline Flex Embolization Device with Shield Technology (Pipelin

Micro Therapeutics, Inc. d/b/a ev3 Neurovascular · Decision date May 15, 2026

FDA DECISIONP100018/S053

What did the FDA decide?

FDA records P100018/S053 as a supplement to PMA P100018, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated May 15, 2026.

FDA approval order statement

approval for the relocation of the Pipeline Flex and Pipeline Shield heat treatment and passivation operations from an ISO 8 Controlled Environment Area (CEA) to a Non-Controlled Area (Non-CEA) and the repositioning of the Pipeline implant braider within the Non-CEA
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Neurology
Decision date
May 15, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P100018/S053
Regulatory pathway
PMA supplement
Product code
OUT
Decision code
OK30
Decision date
May 15, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Intracranial aneurysm flow diverter.

Product code
OUT
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P100018/S048 · Related supplement

    Pipeline Vantage Embolization Device with Shield Technology

  2. P100018/S052 · Related supplement

    PIPELINE EMBOLIZATION DEVICE

  3. P100018/S053 received

    Application receipt date recorded by FDA.

  4. P100018/S053 · FDA decision

    30-Day Notice

  5. P100018/S054 · Related supplement

    Pipeline Flex Embolization Device with Shield Technology (Pipeline Shield); Pipeline Vantage Embolization Device wit

  6. P100018/S055 · Related supplement

    Pipeline Flex Embolization Device (Pipeline Flex); Pipeline Flex Embolization Device with Shield Technology (Pipelin

Timeline entries are records held by MedtechLedger for P100018. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P100018

Explore the linked device profile

Other records with product code OUT

Product / regulatory recordCompanyPathwayDecision dateSource
Stryker NeurovascularPMA supplementAug 28, 2026FDA
Stryker NeurovascularPMA supplementJun 26, 2026FDA
Microvention, Inc.PMA supplementNov 2, 2025FDA
Microvention, Inc.PMA supplementSep 20, 2025FDA
FRED X SystemP180027/S014
Microvention, Inc.PMA supplementSep 18, 2025FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Micro Therapeutics, Inc. d/b/a ev3 Neurovascular

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
9775 Toledo Way, Irvine, CA, 92618

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records